Literature DB >> 422708

Acromegaly associated with a bronchial carcinoid tumor: evidence for ectopic production of growth hormone-releasing activity.

M Saeed uz Zafar, R C Mellinger, G Fine, M Szabo, L A Frohman.   

Abstract

A patient with acromegaly, pituitary enlargement, and elevated plasma GH levels also had a bronchial carcinoid tumor. Signs and symptoms of active acromegaly along with elevated GH levels persisted for 11 yr after hypophysectomy and pituitary stalk section. Resection of the bronchial carcinoid reduced plasma GH to barely detectable levels. Extracts of the frozen carcinoid tumor were devoid of significant GH, but when added to isolated pituitary cells of estrogen-primed male rats in 4-day primary culture exhibited specific GH-releasing activity in vitro. These findings strongly suggest that the patient's acromegaly resulted from continual stimulation of pituitary somatotrophs by a GH-releasing factor secreted by the bronchial carcinoid.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 422708     DOI: 10.1210/jcem-48-1-66

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.

Authors:  M B Lopes; B D Gaylinn; M O Thorner; M H Stoler
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

2.  Bronchial carcinoids: an analysis of 91 cases.

Authors:  H Mårtensson; G Böttcher; G Hambraeus; F Sundler; H Willen; A Nobin
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

3.  Intrasellar hamartoma associated with pituitary adenoma.

Authors:  F Slowik; I Fazekas; K Bálint; L Gazsó; E Pásztor; S Czirják; K Lapis
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 4.  Ectopic secretion of growth hormone-releasing hormone in man.

Authors:  M Losa; J Schopohl; K von Werder
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

5.  Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.

Authors:  J A Goldman; M E Molitch; M O Thorner; W Vale; J Rivier; S Reichlin
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

6.  Human pancreatic tumor GH-releasing factor.

Authors:  M O Thorner; W S Evans; M Vance; J L Borges; R M Blizzard; A D Rogol; R M MacLeod; M J Cronin; L A Frohman; J L Thominet
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

7.  Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man.

Authors:  L A Frohman; J L Thominet; C B Webb; M L Vance; H Uderman; J Rivier; W Vale; M O Thorner
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

8.  Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.

Authors:  M O Thorner; R L Perryman; M J Cronin; A D Rogol; M Draznin; A Johanson; W Vale; E Horvath; K Kovacs
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

Review 9.  Acromegaly update--etiology, diagnosis and management.

Authors:  S Melmed; J A Fagin
Journal:  West J Med       Date:  1987-03

10.  Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly.

Authors:  L A Frohman; M Szabo; M Berelowitz; M E Stachura
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.